Hims & Hers Health Inc. HIMS shares are trading higher Tuesday after the company reported strong third-quarter results and raised its full-year revenue outlook. Here’s what you need to know.
What To Know: Hims & Hers Health reported third-quarter earnings per share of 32 cents, beating estimates of 4 cents. Revenue for the quarter reached $401.6 million, surpassing expectations of $382.2 million and marking a substantial rise from $226.7 million in the same period last year.
The company said its subscriber base has grown to 2 million, representing a 44% increase year-over-year. Gross margin for the third quarter was 79%. Hims & Hers also reported net income of $75.6 million, representing a significant turnaround from the $7.6 million net loss reported in third quarter of 2023.
“In the third quarter, we eclipsed 2 million subscribers on our platform, with more than 1 million utilizing a personalized solution. These are significant milestones and confirm we are on a path to helping an American in every household feel great through the power of better health,” said Andrew Dudum, co-founder and CEO of Hims & Hers Health.
Hims & Hers raised its fiscal 2024 revenue guidance to $1.46 billion to $1.465 billion, versus estimates of $1.396 billion. The company said it expects fourth-quarter revenue to range between $465 million and $470 million.
Following the print, Canaccord Genuity analyst Maria Ripps maintained Hims & Hers Health with a Buy rating and raised the price target from $24 to $28.
Hims Price Action: Hims & Hers shares were up 5.39% at $21.89 at the time of writing, according to Benzinga Pro.
Read Next:
Image: Mohamed Hassan from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
